JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263224

Human GTF3C6 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

GTF3C6 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 1.
1 Images
Sanger Sequencing - Human GTF3C6 knockout HEK-293T cell lysate (AB263224)
  • Sanger seq

Unknown

Sanger Sequencing - Human GTF3C6 knockout HEK-293T cell lysate (AB263224)

Homozygous : 2 bp deletion in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 1.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263224-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human GTF3C6 knockout HEK293T cell lysate", "number":"AB263224-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB263224-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
GTF3C6
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GTF3C6 also known as Transcription Factor IIIC subunit 6 is a component of the transcription factor IIIC (TFIIIC) complex. It weighs approximately 78 kilodaltons and plays a mechanical role in the transcription process. GTF3C6 facilitates the assembly of the TFIIIC complex on DNA enabling the recruitment of RNA polymerase III. The protein is expressed in various tissues reflecting its role in basic cellular functions.
Biological function summary

The protein contributes to the transcription of small non-coding RNA genes such as 5S rRNA and tRNAs. GTF3C6 is a subunit of the TFIIIC complex and its function involves the recognition of specific promoter elements on DNA which is imperative for initiating transcription. By participating in the recognition and structuring of promoter regions GTF3C6 ensures proper transcription activation necessary for cell growth and metabolism.

Pathways

The engagement of GTF3C6 in RNA polymerase III transcription is significant. It operates within the RNA polymerase III transcription pathways interacting with TFIIIB and RNA polymerase III which are key components of the transcription machinery. GTF3C6 plays a role in the complex network of transcription regulation ensuring the timely transcription of essential RNAs that regulate protein synthesis and cell cycle progression.

Altered expression or dysfunction of GTF3C6 may associate with certain types of cancers. Given its role in transcription regulation deviations in GTF3C6 activity can disrupt normal cell proliferation processes. Association between GTF3C6 and other proteins in the RNA polymerase III pathway such as TFIIIB has shown relevance in studies of oncogenesis and potential cancer treatment avenues. Understanding these relationships can open doors to targeted therapies for diseases that involve dysregulation of transcription.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com